These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9555001)
21. Overexpression of hippocampal cholinergic neurostimulating peptide in heterozygous transgenic mice increases the amount of ChAT in the medial septal nucleus. Uematsu N; Matsukawa N; Kanamori T; Arai Y; Sagisaka T; Toyoda T; Yoshida M; Ojika K Brain Res; 2009 Dec; 1305():150-7. PubMed ID: 19815004 [TBL] [Abstract][Full Text] [Related]
22. Age-dependent changes in HCNP-related antigen expression in the human hippocampus. Yuasa H; Ojika K; Mitake S; Katada E; Matsukawa N; Otsuka Y; Fujimori O; Hirano A Brain Res Dev Brain Res; 2001 Mar; 127(1):1-7. PubMed ID: 11287059 [TBL] [Abstract][Full Text] [Related]
23. Reduction of glutamatergic activity through cholinergic dysfunction in the hippocampus of hippocampal cholinergic neurostimulating peptide precursor protein knockout mice. Suzuki K; Ohi Y; Sato T; Tsuda Y; Madokoro Y; Mizuno M; Adachi K; Uchida Y; Haji A; Ojika K; Matsukawa N Sci Rep; 2022 Nov; 12(1):19161. PubMed ID: 36357544 [TBL] [Abstract][Full Text] [Related]
24. Sequence homology of rat and human HCNP precursor proteins, bovine phosphatidylethanolamine-binding protein and rat 23-kDa protein associated with the opioid-binding protein. Tohdoh N; Tojo S; Agui H; Ojika K Brain Res Mol Brain Res; 1995 Jun; 30(2):381-4. PubMed ID: 7637590 [TBL] [Abstract][Full Text] [Related]
25. Enhancement of long-term potentiation via muscarinic modulation in the hippocampus of HCNP precursor transgenic mice. Ohi Y; Kato D; Mizuno M; Sato T; Ueki Y; Borlongan CV; Ojika K; Haji A; Matsukawa N Neurosci Lett; 2015 Jun; 597():1-6. PubMed ID: 25899776 [TBL] [Abstract][Full Text] [Related]
26. Phosphorylation of collapsin response mediator protein-2 regulates its localization and association with hippocampal cholinergic neurostimulating peptide precursor in the hippocampus. Mizuno M; Kato D; Kanamori T; Toyoda T; Suzuki T; Ojika K; Matsukawa N Neurosci Lett; 2013 Feb; 535():122-7. PubMed ID: 23276635 [TBL] [Abstract][Full Text] [Related]
27. Neuronal expression of hippocampal cholinergic neurostimulating peptide (HCNP)-precursor mRNA in rat brain. Taiji M; Tohdoh N; Ojika K J Neurosci Res; 1996 Aug; 45(3):202-15. PubMed ID: 8841981 [TBL] [Abstract][Full Text] [Related]
28. Reduction of acetylcholine in the hippocampus of hippocampal cholinergic neurostimulating peptide precursor protein knockout mice. Kondo-Takuma Y; Mizuno M; Tsuda Y; Madokoro Y; Suzuki K; Sato T; Takase H; Uchida Y; Adachi KI; Hida H; Borlongan CV; Matsukawa N Sci Rep; 2021 Nov; 11(1):22072. PubMed ID: 34764402 [TBL] [Abstract][Full Text] [Related]
29. High levels of hippocampal cholinergic neurostimulating peptide (HCNP) in the CSF of some patients with Alzheimer's disease. Tsugu Y; Ojika K; Matsukawa N; Iwase T; Otsuka Y; Katada E; Mitake S Eur J Neurol; 1998 Nov; 5(6):561-569. PubMed ID: 10210891 [TBL] [Abstract][Full Text] [Related]
30. Distribution of hippocampal cholinergic neurostimulating peptide (HCNP)-like immunoreactivity in organs and tissues of young Wistar rats. Katada E; Mitake S; Matsukawa N; Otsuka Y; Tsugu Y; Fujimori O; Ojika K Histochem Cell Biol; 1996 Jan; 105(1):43-51. PubMed ID: 8824905 [TBL] [Abstract][Full Text] [Related]
31. Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease. Maki M; Matsukawa N; Yuasa H; Otsuka Y; Yamamoto T; Akatsu H; Okamoto T; Ueda R; Ojika K J Neuropathol Exp Neurol; 2002 Feb; 61(2):176-85. PubMed ID: 11853019 [TBL] [Abstract][Full Text] [Related]
32. The unsolved mystery of hippocampal cholinergic neurostimulating peptide: A potent cholinergic regulator. Cho JY; Matsukawa N Brain Circ; 2021; 7(1):29-32. PubMed ID: 34084974 [TBL] [Abstract][Full Text] [Related]
33. Neuropeptide Y release from cultured hippocampal neurons: stimulation by glutamate acting at N-methyl-D-aspartate and AMPA receptors. Gemignani A; Marchese S; Fontana G; Raiteri M Neuroscience; 1997 Nov; 81(1):23-31. PubMed ID: 9300398 [TBL] [Abstract][Full Text] [Related]
34. The emerging cardioinhibitory role of the hippocampal cholinergic neurostimulating peptide. Angelone T; Goumon Y; Cerra MC; Metz-Boutigue MH; Aunis D; Tota B J Pharmacol Exp Ther; 2006 Jul; 318(1):336-44. PubMed ID: 16608915 [TBL] [Abstract][Full Text] [Related]
35. Metabotropic glutamate receptor 5 activation enhances tyrosine phosphorylation of the N-methyl-D-aspartate (NMDA) receptor and NMDA-induced cell death in hippocampal cultured neurons. Takagi N; Besshoh S; Marunouchi T; Takeo S; Tanonaka K Biol Pharm Bull; 2012; 35(12):2224-9. PubMed ID: 23207774 [TBL] [Abstract][Full Text] [Related]
36. Possible implication of hippocampal cholinergic neurostimulating peptide (HCNP)-related components in Hirano body formation. Mitake S; Katada E; Otsuka Y; Matsukawa N; Iwase T; Tsugu T; Fujimori O; Ojika K Neuropathol Appl Neurobiol; 1996 Oct; 22(5):440-5. PubMed ID: 8930956 [TBL] [Abstract][Full Text] [Related]
37. Brain malformations caused by retroviral vector-mediated gene transfer of hippocampal cholinergic neurostimulating peptide precursor protein into the CNS via embryonic mice ventricles. Matsukawa N; Ikenaka K; Nanmoku K; Yuasa H; Hattori M; Kawano M; Nakazawa H; Fujimori O; Ueda R; Ojika K Dev Neurosci; 2003; 25(5):349-56. PubMed ID: 14614262 [TBL] [Abstract][Full Text] [Related]